We are live on
!
Find out more
A
AustralianSuper Portfolio holdings
AUM
$19.2B
1-Year Est. Return
31.95%
This Fund
S&P 500
This Quarter
Est. Return
-15.67%
1 Year Est. Return
+31.95%
3 Year Est. Return
+101.58%
5 Year Est. Return
+115.19%
10 Year Est. Return
–
AUM
$16.2M
AUM Growth
-$2.2M
(-12%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
6,600.01%
Top 10 Holdings %
Top 10 Hldgs %
35.09%
Holding
198
New
16
Increased
100
Reduced
56
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$255M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$202M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$174M |
| 4 |
Apple
AAPL
|
+$167M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$171M |
| 2 |
Veeva Systems
VEEV
|
+$170M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$169M |
| 4 |
VF Corp
VFC
|
+$123M |
| 5 |
Adobe
ADBE
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 17.3% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 12.99% |
| 5 | Materials | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ametek
AME
$54.3B
| $198K | 1.22% |
1,802,025
-369,662
| -17% | -$44.9M |
|
27
Icon
ICLR
$13.1B
| $196K | 1.21% |
906,452
| – | – |
|
28
Stryker
SYK
$123B
| $194K | 1.2% |
976,877
-128,032
| -12% | -$30.1M |
|
|
29
Bio-Rad Laboratories Class A
BIO
$8.15B
| $192K | 1.18% |
+387,567
| New | +$202M |
|
30
Ferrari
RACE
$66.3B
| $190K | 1.17% |
1,034,584
-78,387
| -7% | -$15.6M |
|
|
31
Apple
AAPL
$4.9T
| $151K | 0.93% |
+1,103,000
| New | +$167M |
|
32
Electronic Arts
EA
$52.4B
| $149K | 0.92% |
1,226,540
-845,780
| -41% | -$108M |
|
33
Match Group
MTCH
$9.13B
| $146K | 0.9% |
2,100,572
-122,053
| -5% | -$9.9M |
|
34
Becton Dickinson
BDX
$43.6B
| $139K | 0.86% |
562,844
+258,041
| +85% | +$65.5M |
|
|
ANSS
35
DELISTED
Ansys
ANSS
| $123K | 0.76% |
514,289
-307,785
| -37% | -$81.4M |
|
36
Bristol-Myers Squibb
BMY
$124B
| $120K | 0.74% |
1,559,347
+71,054
| +5% | +$5.41M |
|
37
General Motors
GM
$68.6B
| $119K | 0.73% |
3,735,719
+199,744
| +6% | +$7.49M |
|
38
O'Reilly Automotive
ORLY
$71.3B
| $111K | 0.69% |
2,640,000
+436,020
| +20% | +$18.8M |
|
|
39
Thermo Fisher Scientific
TMO
$198B
| $111K | 0.68% |
203,525
-306,891
| -60% | -$169M |
|
40
Advanced Micro Devices
AMD
$808B
| $110K | 0.68% |
1,440,000
+600,000
| +71% | +$56.2M |
|
|
41
Adobe
ADBE
$94.3B
| $105K | 0.65% |
287,645
-270,955
| -49% | -$110M |
|
42
Illumina
ILMN
$28.2B
| $105K | 0.65% |
585,890
-121,844
| -17% | -$31.1M |
|
|
43
Estee Lauder
EL
$29.7B
| $101K | 0.62% |
395,162
-673,844
| -63% | -$171M |
|
44
Accenture
ACN
$87.9B
| $97.6K | 0.6% |
351,635
+179,043
| +104% | +$53.8M |
|
45
Qualcomm
QCOM
$181B
| $93.1K | 0.57% |
728,755
+258,102
| +55% | +$35M |
|
46
Moderna
MRNA
$24.5B
| $92K | 0.57% |
643,720
+409,891
| +175% | +$58.6M |
|
47
3M
MMM
$83.4B
| $91.4K | 0.56% |
844,555
+672,601
| +391% | +$81.3M |
|
48
HP
HPQ
$22.7B
| $91.3K | 0.56% |
2,784,699
+149,912
| +6% | +$5.5M |
|
49
Johnson & Johnson
JNJ
$609B
| $88.9K | 0.55% |
500,836
+113,882
| +29% | +$20.3M |
|
50
Booking.com
BKNG
$141B
| $81.6K | 0.5% |
1,166,075
+327,650
| +39% | +$28M |
|
Similar funds
CS
LF
PCM
MGP
SOMRS
BPA
NAM
AustralianSuper's Q2 2022 Portfolio in Review
As of Q2 2022, AustralianSuper held 198 positions worth $16.2M, down 12% from $18.4M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
AustralianSuper deployed $1.07B of net new capital in Q2 2022, opening 16 new positions and adding to 100 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 387,567 shares worth $192K.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Estee Lauder, an estimated $171M trimmed.
- AustralianSuper's largest Q2 2022 buy was Bio-Rad Laboratories Class A: 387,567 shares worth $192K.
- AustralianSuper added most to Intuit in Q2 2022, an estimated $255M increase.
- AustralianSuper's biggest Q2 2022 reduction was Estee Lauder, cutting an estimated $171M.
- AustralianSuper fully exited Goldman Sachs in Q2 2022, selling an estimated $86.5K.
- AustralianSuper's ten largest holdings make up 35% of its $16.2M portfolio in Q2 2022.
- AustralianSuper opened 16 new positions and closed 23 in Q2 2022.
- AustralianSuper's portfolio value fell 12% quarter-over-quarter to $16.2M.
Based on AustralianSuper's 13F filing for Q2 2022, filed 13 Jul 2022.